National Health Care Anti-Fraud Association names it’s 2015 Investigation of the Year

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE NATIONAL HEALTH CARE ANTI-FRAUD ASSOCIATION today presented its Investigation of the Year Award to a team of federal agencies together with a private health insurer for their collaborative work on the case of United States of America v. Farid Fata, MD.

This investigation involved a leading hematologist-oncologist in Michigan who misdiagnosed and mistreated hundreds of his patients for conditions they did not have, including cancer, in order to maximize billing to Medicare and private insurance.

Over the course of four days, the initial tip was received, allegations were verified, and search warrants and criminal complaints were prepared, resulting in Fata’s arrest.

On July 10, Fata was sentenced to 45 years in federal prison and ordered to forfeit $17.6 million for violating the trust of 553 patients and for submitting approximately $34 million in fraudulent claims. At his sentencing, U.S. District Judge Paul Borman said, “This is a huge, horrific series of criminal acts that were committed by the defendant,” and then said that Fata “practiced greed and shut down whatever compassion he had.”

The awardees are: the Fraud Section of the Department of Justice Criminal Division; the Office of Investigations under the Inspector General of the Department of Health and Human Services; the Criminal Investigation department of the Internal Revenue Service; U.S. Attorney’s Office for the Eastern District of Michigan; the FBI Detroit Field Office; and Blue Cross Blue Shield of Michigan Corporate and Financial Investigations.

YOU MAY BE INTERESTED IN

“I don’t know of a single grant that left my desk that was not approved and funded,” NCI Director Anthony G. Letai said on this episode of The Cancer Letter Podcast. https://open.spotify.com/episode/2PFYGwliBDYEbxBXFd9MtB?si=95DNBAy0QGSKBX31_uETEA This episode is available on Spotify, Apple Podcasts, and Youtube. Letai recapped his first year as NCI director in conversation with Paul Goldberg,...

A year ago, when he was sworn in as director of the National Cancer Institute, Anthony G. Letai set a goal: Reassure cancer researchers that the institute will keep a steady course aimed at finding treatments for cancer.
Michael R. Caputo, a cancer survivor and a Republican political operative with a wide-ranging resume, was named to the President’s Cancer Panel, a board formed under the National Cancer Act to monitor the National Cancer Program and report to the president about “barriers to progress in reducing the burden of cancer.”
For over two decades, the ASCO Genitourinary Cancers Symposiumhas stood as the premier global event that has helped advance cancer science and transform care. The 2027 Symposium will continue this legacy from Feb. 11–13 in San Francisco by bringing together the largest international audience in GU oncology to help define tomorrow’s standards of care. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login